AdipoLABs Co., Ltd. and Red & Blue Co., Ltd. from Korea, together with their Malaysian subsidiary, AdipoLABs Healthcare (M) Sdn Bhd, have officially opened a new regional office for Asia-Pacific in Malaysia. This strategic expansion aims to strengthen the company's leadership in non-invasive healthcare and build a robust MedTech ecosystem across ASEAN. The company simultaneously signed two Memoranda of Understanding with the University of Cyberjaya to formalize a partnership focused on advancing healthcare innovation, clinical research, and talent development.
This collaboration is significant as it directly addresses the need for industry-academia partnerships to bridge the gap between theoretical knowledge and practical application in healthcare. The partnership is designed to drive knowledge transfer, foster research and development collaboration, provide industry-standard training, and enhance preventive healthcare capabilities in the region. Mr. Han Sung-ho, CEO of AdipoLABs Co., Ltd., stated that by uniting their hyperthermia technology with local expertise and academic rigor, they aim to expedite the adoption of advanced solutions and improve patient outcomes worldwide, envisioning this collaboration as a blueprint for international healthcare partnerships.
A cornerstone of the first MoU is a comprehensive six-month internship program with UoC's Physiotherapy programmes under the Faculty of Health, offering students potential job opportunities and invaluable real-world experience. Students will gain hands-on expertise with AdipoLABs' Pain Bot device, enhancing their skills in pain detection and treatment. Biomedical engineering students will support technical operations, strengthening after-sales service and device maintenance. As part of a strategic client engagement initiative, interns may be placed at client facilities to demonstrate device effectiveness and provide on-site support, highlighting their value and encouraging potential permanent employment while ensuring optimal technology use.
The collaboration extends to clinical research, with UoC professors and students conducting studies on various AdipoLABs medical devices. This research will generate evidence-based insights to be published in reputable journals, scientifically validating the technologies. Dr. Isaac R. Joseph, Director of AdipoLABs Healthcare (M) Sdn Bhd, emphasized the commitment to cultivating local talent and driving Malaysian healthcare innovation, noting that the partnership offers UoC students hands-on experience with technologies like Pain Bot and expands clinical research to enhance pain management solutions for patients across Malaysia and ASEAN.
In a parallel effort, a second MoU focuses on knowledge transfer and medical device donation. Under this agreement, AdipoLABs Malaysia will donate a Pain Bot unit to UoC, giving students direct access to cutting-edge pain detection and treatment technology. This enhances their knowledge and skills in innovative musculoskeletal pain management methods. AdipoLABs, a Ministry of Health-registered medical-device establishment under the Medical Device Authority, anchors this collaboration with proven regulatory credibility, reinforcing UoC's ambition to accelerate evidence-based research and industry-ready healthcare solutions.
Professor Dr. David Whitford, Vice-Chancellor of the University of Cyberjaya, described the partnership as a direct investment in the next generation of healthcare professionals. He stated that with the introduction of advanced rehabilitative technologies, students gain access to international-standard tools and real-world innovation that will shape their confidence, competence, and future careers. Further strengthening the collaboration, Professor Dr. Yoo Seung-mo from South Korea, the inventor of the Pain Bot, will serve as an Adjunct Professor at UoC. Dr. Yoo will provide on-site training and ongoing remote mentorship, ensuring students receive the highest level of expertise in utilizing the Pain Bot technology and applying advanced pain detection and treatment techniques.
The implications of this partnership are substantial for Malaysia's healthcare sector and the broader ASEAN region. It represents a model for integrating international medical technology with local educational institutions to create a sustainable pipeline of skilled professionals. By combining clinical research with practical training, the initiative is poised to improve healthcare delivery standards, validate new medical technologies through rigorous academic study, and potentially influence pain management protocols. For more information, visit https://www.cyberjaya.edu.my or https://adipolabs-msia.com.
